دورية أكاديمية

Bye-bye muscle biopsy, we have autoantibodies with us now.

التفاصيل البيبلوغرافية
العنوان: Bye-bye muscle biopsy, we have autoantibodies with us now.
المؤلفون: Riddell, Victoria, Tansley, Sarah
المصدر: Indian Journal of Rheumatology; 2020 Suppl, Vol. 15, p74-80, 7p
مستخلص: Muscle biopsy is generally considered the gold standard diagnostic tool for patients with presenting with features suggestive of idiopathic inflammatory myopathy. Muscle biopsy is however an invasive test, the histopathological findings can be influenced by previous treatment and not all patients with myositis spectrum disease have muscle involvement. Myositis specific and associated autoantibodies can now be identified in the majority of patients with myositis. When present they identify homogeneous patient subgroups and have the potential to be key tools in developing a personalised approach to disease management. Here we review the utility of myositis specific and associated autoantibodies as diagnostic and prognostic tools. [ABSTRACT FROM AUTHOR]
Copyright of Indian Journal of Rheumatology is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:09733698
DOI:10.4103/injr.injr_114_20